Literature DB >> 8782064

Ischemic preconditioning: bioenergetic and metabolic changes and the role of endogenous adenosine.

J P Headrick1.   

Abstract

The role of adenosine in ischemic preconditioning in different species remains controversial. Ischemic preconditioning was examined in perfused rat and rabbit hearts. In rat and rabbit hearts subjected to 30 min global normothermic ischemia followed by 30 min of reperfusion, left ventricular developed pressure (LVDP) recovered to 36 +/- 8% and 44 +/- 7% of preischemia, respectively. Pre-treatment with transient (6 min) global ischemia improved recovery of LVDP (75 +/- 7% and 82 +/- 9% pre-ischemia, respectively), and improved recovery of coronary flow and end-diastolic pressure. Effects of preconditioning were unrelated to cytosolic [ATP], but were associated with reduced ischemic acidosis, and improved post-ischemic recovery of [Mg2+], [P(i)] and delta GATP. In addition to ischemia, transient episodes of hypoxia (5% O2), norepinephrine stimulation (0.1 microM) or metabolic inhibition (5 mM cyanide minus glycolytic substrate) all improved recovery from prolonged ischemia. Microdialysis revealed that 6 min of ischemic preconditioning increased dialysate [adenosine] from 0.25 to 6.81 +/- 0.87 microM in rat hearts, and from 0.33 to 1.98 +/- 0.41 microM in rabbit hearts. Extracellular [adenosine] was also enhanced during the transient periods of hypoxia, norepinephrine stimulation and metabolic inhibition shown to be protective. Pre-treatment with 0.5 microM Nb-cyclohexyladenosine mimicked preconditioning, and 50 microM 8-(rho-sulfophenyl) theophylline attenuated ischemic preconditioning in rat and rabbit hearts. 8-(rho-sulfophenyl) theophylline also abolished effects of preconditioning on ischemic acidosis, and post-ischemic [Mg2+], [P(i)] and delta GATP. The data demonstrate that (i) preconditioning is triggered by transient periods of energy imbalance: (ii) endogenous adenosine is of primary importance in mediating the cardioprotection following a single transient ischemic stimulus in rat and rabbit hearts; and (iii) post-receptor mechanisms of this adenosine-mediated preconditioning appear to involve reduced ischemic acidosis and enhanced recovery of [P(i)], [Mg2+] and delta GATP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8782064     DOI: 10.1006/jmcc.1996.0113

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  17 in total

Review 1.  Adenosine receptors and reperfusion injury of the heart.

Authors:  John P Headrick; Robert D Lasley
Journal:  Handb Exp Pharmacol       Date:  2009

2.  Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia.

Authors:  G P Matherne; J Linden; A M Byford; N S Gauthier; J P Headrick
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

3.  Cardioprotective effects of adenosine A1 and A3 receptor activation during hypoxia in isolated rat cardiac myocytes.

Authors:  N Safran; V Shneyvays; N Balas; K A Jacobson; H Nawrath; A Shainberg
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

4.  Ischemic and pharmacological preconditioning induces further delayed protection in transgenic mouse cardiac myocytes over-expressing adenosine A1 receptors (A1AR): role of A1AR, iNOS and K(ATP) channels.

Authors:  Mohammed A Nayeem; G Paul Matherne; S Jamal Mustafa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-25       Impact factor: 3.000

5.  In vivo monitoring of hydroxyl radical generation in the rat myocardium in ischemia and reperfusion: the effect of ischemic preconditioning.

Authors:  E I Chazov; E I Kalenikova; E A Gorodetskaya
Journal:  Dokl Biol Sci       Date:  2001 Sep-Oct

6.  Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits.

Authors:  T Miki; M V Cohen; J M Downey
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

7.  Ischemic preconditioning in isolated perfused mouse heart: reduction in infarct size without improvement of post-ischemic ventricular function.

Authors:  L Xi; M L Hess; R C Kukreja
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

8.  Evaluating the protective role of ischaemic preconditioning in rat hearts using a stationary small-animal SPECT imager and 99mTc-glucarate.

Authors:  Zhonglin Liu; Harrison H Barrett; Gail D Stevenson; Lars R Furenlid; Koon Yan Pak; James M Woolfenden
Journal:  Nucl Med Commun       Date:  2008-02       Impact factor: 1.690

9.  Insights into the cardioprotective function of adenosine A(1) and A(3) receptors.

Authors:  Vladimir Shneyvays; Liaman K Mamedova; Dorit Leshem; Avishag Korkus; Asher Shainberg
Journal:  Exp Clin Cardiol       Date:  2002

10.  Optimizing human apyrase to treat arterial thrombosis and limit reperfusion injury without increasing bleeding risk.

Authors:  Douglas Moeckel; Soon Soeg Jeong; Xiaofeng Sun; M Johan Broekman; Annie Nguyen; Joan H F Drosopoulos; Aaron J Marcus; Simon C Robson; Ridong Chen; Dana Abendschein
Journal:  Sci Transl Med       Date:  2014-08-06       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.